News

Filter by Category

Filter by Program

Filter by Publish Date

April 11, 2025

2025 Clinical Outcome Assessment Program Annual Meeting Recap

On April 9-10, 2025, the 2025 Clinical Outcome Assessment...

April 11, 2025

In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...

April 2, 2025

C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...

March 10, 2025

C-Path is excited to welcome CND Life Sciences as the newest member of it Critical Path for Parkinson’s (CPP)...

February 20, 2025

Critical Path for Parkinson's Consortium (CPP) Advisor and FDA Advisory Committee Member Sarah Zenner-Dolan...

February 19, 2025

At C-Path’s INC, we believe that meaningful progress in neonatal drug development...

February 19, 2025

C-Path's eCOA Consortium is thrilled to welcome Veeva Systems and VPG Health...

February 18, 2025

Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.

February 13, 2025

Pediatric drug development faces signiﬁcant challenges, including underfunding, ethical concerns, and complex regulatory...

January 31, 2025

C-Path has developed a framework to support FDA qualification of CIVMs for use in regulatory submissions.